financetom
Business
financetom
/
Business
/
Pacific Gas & Electric Holds The Line On Q4 EPS Amid Grid Modernization Push: Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pacific Gas & Electric Holds The Line On Q4 EPS Amid Grid Modernization Push: Details
Feb 14, 2025 9:56 AM

Pacific Gas & Electric Co. shares are trading lower on Friday. On Thursday, the company reported fourth-quarter results, with an adjusted EPS of $0.31, which was in line with the consensus.

PG&E ( PCG ) reported 2024 adjusted EPS of $1.36, up from $1.23 in 2023, aided by higher customer capital investment, as approved in the 2023 General Rate Case final decision, which earns an equity return under the cost of capital proceeding.

Operating cash flow stood at $8.0 billion in 2024, up from $4.7 billion in 2023.

In 2024, non-fuel operating and maintenance (O&M) costs decreased by 4%, surpassing the 2% target. The company has saved over $200 million in non-fuel O&M costs annually for the past three years.

In 2024, the company secured a $15 billion loan guarantee agreement with the U.S. Department of Energy’s Loan Programs Office to fund grid modernization projects, potentially saving customers up to $1 billion on a net present value basis through lower-cost financing.

Outlook: PG&E ( PCG ) raised its 2025 adjusted EPS guidance to $1.48 – $1.52 from its previous estimate of $1.47 – $1.51, vs. the consensus estimate of $1.49.

The company targets a dividend payout ratio of around 20% of core earnings by 2028.

PG&E ( PCG ) CEO Patti Poppe said, “In 2024, we continued progress in ways that matter to both customers and investors. We delivered energy safely—our system has never been safer, and we are working to make it even safer. We stabilized combined gas and electric bills for residential customers. And we connected more new customers to our grid than we have in decades.” 

In a separate release, the company stated that it is planning to support approximately 5.5 gigawatts (GW) of new data center energy demand over the next decade. 

Of this, 1.4 GW is in the final design phase and is expected to become operational between 2026 and 2030.

Investors can gain exposure to the stock via Listed Funds Trust TrueShares Eagle Global Renewable Energy Income ETF  and VanEck Uranium And Nuclear ETF .

Price Action: PCG shares are down 1.86% at $15.56 at the last check Friday.

Read Next:

Dan Loeb’s Third Point Trims Amazon, Microsoft, Meta As Tech Stocks Climb

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lockheed Martin Says Greece to Buy 20 F-35 Lightning II Aircraft
Lockheed Martin Says Greece to Buy 20 F-35 Lightning II Aircraft
Jul 25, 2024
11:21 AM EDT, 07/25/2024 (MT Newswires) -- Lockheed Martin ( LMT ) said Thursday that the Greek government confirmed its plan to buy 20 of the company's F-35 Lightning II aircraft. Greece signed a letter of offer and acceptance through a US government foreign military sale. The agreement also has an option for 20 additional aircraft, the company said. Financial...
What's Going On With NIO Shares Today?
What's Going On With NIO Shares Today?
Jul 25, 2024
NIO Inc. ( NIO ) shares are trading higher on Thursday. According to Benzinga Pro, NIO stock has lost over 63% in the past year. Investors can gain exposure to the stock via KraneShares MSCI China Clean Technology Index ETF ( KGRN ) and KraneShares Electric Vehicles And Future Mobility Index ETF . The head of Onvo, a sub-brand of NIO, reportedly stated...
Pfizer's Hemophilia B Treatment Gets Conditional Marketing Authorization in Europe
Pfizer's Hemophilia B Treatment Gets Conditional Marketing Authorization in Europe
Jul 25, 2024
11:20 AM EDT, 07/25/2024 (MT Newswires) -- Pfizer's ( PFE ) said Thursday the European Commission has granted conditional marketing authorization for Durveqtix to treat severe and moderately severe hemophilia B, a rare genetic bleeding disorder. The approval covers adult patients without a history of factor IX inhibitors and without detectable antibodies to variant adeno-associated virus serotype Rh74, the drugmaker...
Atlanticus Holdings Prices $55 Million Add-On Senior Notes Offering
Atlanticus Holdings Prices $55 Million Add-On Senior Notes Offering
Jul 25, 2024
11:17 AM EDT, 07/25/2024 (MT Newswires) -- Atlanticus Holdings ( ATLC ) said Thursday that it priced its underwritten public add-on offering of $55 million aggregate principal amount of its 9.25% senior notes due 2029 at $24.70 per additional note. The company said it granted the underwriters an option to purchase up to $8.3 million in additional notes at the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved